Patent · US Active

Compositions for treating an intestinal inflammatory condition

US8992907B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

TXCELL · FR

Inventor

Arnaud Foussat · Biot, FR

Key dates

Filing date	Nov 26, 2008
Grant date	Mar 31, 2015
Priority date	—
Expiry date	Oct 13, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2501/23
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions comprising human Tr1 cells directed to a food antigen from common human diet and methods for treating an intestinal inflammatory condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.